Roche Aktie
291,20
EUR
+6,20
EUR
+2,18
%
272,30
CHF
+7,20
CHF
+2,72
%
Werbung
Roche Aktie Analyse
25.04.22 | Roche Sell | UBS AG | |
25.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
25.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
19.04.22 | Roche Buy | Jefferies & Company Inc. | |
19.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
19.04.22 | Roche Sell | UBS AG | |
13.04.22 | Roche Equal-weight | Morgan Stanley | |
12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
Werbung
|
|||
12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
31.03.22 | Roche Buy | Deutsche Bank AG | |
30.03.22 | Roche Overweight | Barclays Capital | |
30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
30.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
30.03.22 | Roche Outperform | Bernstein Research | |
29.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
11.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
21.02.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
16.02.22 | Roche Buy | Deutsche Bank AG | |
11.02.22 | Roche Neutral | UBS AG | |
11.02.22 | Roche Buy | Jefferies & Company Inc. | |
09.02.22 | Roche Buy | Deutsche Bank AG | |
07.02.22 | Roche Buy | Deutsche Bank AG | |
07.02.22 | Roche Overweight | Barclays Capital | |
04.02.22 | Roche Overweight | Barclays Capital | |
04.02.22 | Roche Neutral | UBS AG | |
03.02.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
03.02.22 | Roche Neutral | JP Morgan Chase & Co. | |
03.02.22 | Roche Buy | Jefferies & Company Inc. | |
31.01.22 | Roche Overweight | Barclays Capital | |
26.01.22 | Roche Buy | Deutsche Bank AG | |
26.01.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
24.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
17.01.22 | Roche Buy | Deutsche Bank AG | |
13.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
11.01.22 | Roche Buy | Deutsche Bank AG | |
04.01.22 | Roche Outperform | Bernstein Research | |
04.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
16.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.12.21 | Roche Neutral | UBS AG | |
13.12.21 | Roche Neutral | Credit Suisse Group | |
13.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
10.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
10.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
07.12.21 | Roche Buy | Jefferies & Company Inc. | |
02.12.21 | Roche Neutral | UBS AG | |
24.11.21 | Roche Neutral | UBS AG | |
24.11.21 | Roche Buy | Deutsche Bank AG | |
11.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung